Work

Phase I study of pazopanib (PAZ) in combination with PCI-24781 (PCI) in patients (pts) with metastatic solid tumors with new tumor proliferation imaging correlates in renal cell carcinoma (RCC) and sarcoma.

Year: 2013

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2013.31.15_suppl.tps2623

Authors: Thach-Giao Truong, Jennifer A. Grabowsky, Stephanie Chen, Roth Ea, Andrew H. Ko, Terence W. Friedlander, Emily K. Bergsland, Andrea Lynne Harzstark, Anne Reinert, Gordon Fung, Adil Daud, Pamela N. Munster

Institutions: UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, University of California San Francisco Medical Center

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2599309526

Cites:

Cited by:

Related to: 10